The company disclosed preliminary results in mid January, but it left out important metrics such as earnings per share for the fourth quarter.
Jefferies analyst Akash Tewari maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on February 3 and set a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback